Baidu
map

政策与人文

订阅

MedSci主页 / 所有栏目 / 政策与人文

通往未来医疗的5大趋势

2015-05-27 佚名 奇点网

未来医疗　趋势
关注

对于大多数人而言，“机器人医生”(the robot doctor)听起来像是某部恐怖科幻电影的片名。但它却是未来医学的一个核心组成部分。 数据革命正在改变医疗保健市场的前景，如果你也参与到其中，成为推动医疗变革的一份子，需要为以下五个令人兴奋的趋势做好准备： 1. 预防医学时代来临 由于电子病历(EMR)信息可通过云端访问，医疗保健相关工作也开始向线上转移。诊断走向

对于大多数人而言，“机器人医生”(the robot doctor)听起来像是某部恐怖科幻电影的片名。但它却是未来医学的一个核心组成部分。
 
数据革命正在改变医疗保健市场的前景，如果你也参与到其中，成为推动医疗变革的一份子，需要为以下五个令人兴奋的趋势做好准备：
 
1. 预防医学时代来临
 
由于电子病历(EMR)信息可通过云端访问，医疗保健相关工作也开始向线上转移。诊断走向数字化意味着预测和预防医学时代即将到来。通过记录微小的体温变化，或检测病毒的初期症状，传感器很容易让消费者在生病之前好好照顾自己。
 
但目前这项技术尚处于初期发展阶段，需要更多的创业者来进一步挖掘其潜力。你可以通过密切关注该领域的趋势和创新来帮助重塑医疗市场的未来。要做到这一点，可以与当地大学展开合作，看看能否从中得到启发，或参加一些培训项目，如StartUp Health Academy。
 
2. 医疗保健服务从通用转向个性化
 
物联网(IoT)将把支持预测医学的设备，与把患者健康与其生活方式结合在一起的产品连接在一起，将来这一趋势将变得很普遍。由于数据越来越易于访问，设备变得越来越智能，创业者可以轻松地将这些新技术与患者体验相结合。
 
因此，创业者应专注于数据的获取和分析，并掌握最新的技术动态。总之，要在革命到来之前积极投资数据。
 
3. 机器人将针对医疗健康任务进行优化
 
预测性数据解决方案的发展将催生出能够独立完成健康护理任务的设备和机器人。当前，已经有一些原型产品走进医院。例如，Aethon公司开发的Eve机器人已经走进加州大学旧金山分校医疗中心，可运送病毒样本和医用品。
 
要进入该市场，创业者最好先在这方面接受教育和培训。 Codecademy和Coursera等就提供类似的培训课程或项目，而且通常为免费服务。将接受教育与最新的趋势动态相结合，为将来的成功奠定基础。
 
4. 广泛地合作胜于闭门造车
 
能与研究人员、医疗健康机构和其他行业厂商合作的创业者，将成为改革的引领者，在市场上找到突破口。
 
与医疗保健专业人员和创业者网络建立起联系能够带来极大的合作威力。芝加哥Matter等孵化器在这方面表现突出，能把创业者与大企业、研究机构和投资者紧密联系在一起。要想在该领域创业成功，要尽可能参与到这样的环境中。
 
5. 医生将接入更多数据
 
医生已经在使用计算机和其他高科技设备来提升医疗护理工作。由于数据越来越广泛，越来越个性化，且越来越已于访问，这将对医生诊断疾病和治疗患者的方式带来革命。
 
例如，彼得·迪曼蒂斯(Peter Diamandis)博士领导的创新机构X Prize Foundation拿出了1000万美元来支持“三录仪”(Tricorder)的开发。三录仪是电影《星际迷航》中的一个万用工具，能感知周围环境，对人体进行扫描以检测病患等。迪曼蒂斯预计，该设备有望在未来五年内研发成功。
 
能适应和接受新技术，为医生提供最新的诊断工具，这样的创业者就会充分利用数据革命所带来的优势。
 
大家可能会注意到，这五大趋势有一个共同点：数据。企业只有掌握了数据，才能强化自身的创新能力。抓住技术优势所提供的机会，你就会成为这个时代的创新者。现在重新再谈前文的“机器人医生”，你是不是觉得不再那么不可思议了？

(原文标题：通往未来医疗的5大趋势就在这儿了！)

原始出处：


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-10-14 1249857fm32暂无昵称

    #未来医疗#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-31 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-28 mrliu

    了解

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-28 mrliu

    了解

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-28 mrliu

    了解

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-28 mrliu

    了解

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2054019, encodeId=c97920540192b, content=<a href='/topic/show?id=28b16086327' target=_blank style='color:#2F92EE;'>#未来医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60863, encryptionId=28b16086327, topicName=未来医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Wed Oct 14 10:35:00 CST 2015, time=2015-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25605, encodeId=f5e325605a2, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:25:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25150, encodeId=b53d2515091, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25151, encodeId=4da225151c4, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25152, encodeId=911125152b1, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25153, encodeId=55642515318, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea381623485, createdName=mrliu, createdTime=Thu May 28 09:08:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25145, encodeId=08b525145e2, content=大白真的来到人类, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Thu May 28 03:43:00 CST 2015, time=2015-05-28, status=1, ipAttribution=)]
    2015-05-28 zhouanxiu

    大白真的来到人类

    0

Baidu
map
Baidu
map
Baidu
map